Individualizing cardiac care, the field of Cardiac Personalized Medicine is at the forefront of transforming cardiovascular treatment paradigms. This innovative approach tailors medical interventions for heart health based on an individual's distinct genetic composition, lifestyle, and specific cardiac conditions. By embracing cutting-edge technologies, including genetics, biomarkers, and diagnostics, Cardiac Personalized Medicine aims to redefine how we approach prevention, diagnosis, and treatment of cardiovascular diseases. The personalized aspect extends beyond genetics, considering lifestyle factors and patient-specific cardiac nuances. The potential impact of Cardiac Personalized Medicine is profound, as it strives to not only enhance treatment precision but also to create a more patient-centered cardiovascular healthcare landscape. As advancements in research and technology persist, the evolution of personalized medicine promises to be a key driver in optimizing cardiac care outcomes.
Title : Personalized and precision medicine (PPM) as a unique healthcare model through biodesign-driven translational applications and cardiology-related healthcare marketing to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Beyond weight loss and diabetes control GLP 1 agonists paradigm shift in Cardiovascular care .
Syed Raza, Awali Hospital, Bahrain
Title : Vericiguat Inhibits the Progress of Cardiac Hypertrophy and Prevents Hypertrophy Induced Heart Failure by Multiple Mechanisms
Guo Wei He, TEDA International Cardiovascular Hospital, Tianjin University, China
Title : Coronary revascularization in patients with diabetes: Prospects for stenting in patients with type 1 diabetes and coronary artery disease
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation
Title : STEMI versus acute occlusive myocardial infarction: Which term should we use?
Yochai Birnbaum, Baylor College of Medicine, United States
Title : Chronic angina and the health economics of cardiovascular risk reduction in macro- and microvascular coronary disease
Uwe Peter Tigor, Auxilius Pharma, United States